UB Opiod Training test | Questions With Correct
Answers | A+ Graded | Success Guaranteed!
New York's prescription monitoring program, I-STOP - ANSWER must be carefully consulted
before prescribing CII, CIII, CIV controlled substances
In NYS, initial opioid prescribing is limited to a 7 day supply for which of the following conditions
- ANSWER acute pain
under which of the following circumstances may controlled substances NOT be prescribed using
a written NYS prescription instead electronically - ANSWER patient request
all of the following are legally required to be included ion a electronic prescription EXCEPT:
a. digital signature
b. indication
c. brand or generic drug name
d. prescribers NPI number - ANSWER indication
Which of the following statements is true regarding the prescribing of opioid antagonist like
naloxone in NYS? - ANSWER prescribing is required with the first opioid prescription of the year
for patients with a history of substances use disorder
in NYS, legal requirement related to a written treatment plan for chronic opioid use include all
of the following EXCEPT - ANSWER applies to patients with active cancer and those under
hospice and palliative care
A 43-year-old patient in our outpatient clinic started opioids eight years ago. They are currently
taking 60 MME of opioid medication per day. After discussion of potential risks and benefits,
you and the patient collaboratively decide to gradually taper to a dose below 50 MME per day.
, After the initial dose reduction, they are experiencing withdrawl symptoms. All of the following
are true in the situation EXCEPT:
a. The patient may resort to other methods of obtaining opioids to address withdrawl
symptoms
b. The patient may be at risk of experiencing pain exacerbation, psychological distress and/or
suicidal ideation
c. Adding a benzodiazepine to treat withdrawal symptoms is recommended
d. Slowing or pausing the taper may be beneficial to minimize the withdrawal symptoms -
ANSWER Adding a benzodiazepine to treat withdrawal symptoms is recommended
Which of the following statements is true regarding pain management
a. Pain is a vital protective mechanism that allows us to win and environment full of potential
dangers
b. Assessment of risk of developing substance use disorders for an individual patient only needs
to be done once at baseline
c. Short acting opioid medication's would usually be expected to eliminate a patient's pain
entirely
d. generally, non-opioid medications should be used first line prior to opioid medications -
ANSWER generally, non-opioid medications should be used first line prior to opioid medications
When starting opioid therapy for sub acute or chronic pain, reevaluate risks and benefits
a. Within one year after starting opioids I will be
b. Within 6-8 months after starting opioids I will be
c. Within 12-16 weeks after starting opioids I will be
d. Within 1-4 weeks after starting opioids I will be - ANSWER Within 1-4 weeks after starting
opioids I will be
Answers | A+ Graded | Success Guaranteed!
New York's prescription monitoring program, I-STOP - ANSWER must be carefully consulted
before prescribing CII, CIII, CIV controlled substances
In NYS, initial opioid prescribing is limited to a 7 day supply for which of the following conditions
- ANSWER acute pain
under which of the following circumstances may controlled substances NOT be prescribed using
a written NYS prescription instead electronically - ANSWER patient request
all of the following are legally required to be included ion a electronic prescription EXCEPT:
a. digital signature
b. indication
c. brand or generic drug name
d. prescribers NPI number - ANSWER indication
Which of the following statements is true regarding the prescribing of opioid antagonist like
naloxone in NYS? - ANSWER prescribing is required with the first opioid prescription of the year
for patients with a history of substances use disorder
in NYS, legal requirement related to a written treatment plan for chronic opioid use include all
of the following EXCEPT - ANSWER applies to patients with active cancer and those under
hospice and palliative care
A 43-year-old patient in our outpatient clinic started opioids eight years ago. They are currently
taking 60 MME of opioid medication per day. After discussion of potential risks and benefits,
you and the patient collaboratively decide to gradually taper to a dose below 50 MME per day.
, After the initial dose reduction, they are experiencing withdrawl symptoms. All of the following
are true in the situation EXCEPT:
a. The patient may resort to other methods of obtaining opioids to address withdrawl
symptoms
b. The patient may be at risk of experiencing pain exacerbation, psychological distress and/or
suicidal ideation
c. Adding a benzodiazepine to treat withdrawal symptoms is recommended
d. Slowing or pausing the taper may be beneficial to minimize the withdrawal symptoms -
ANSWER Adding a benzodiazepine to treat withdrawal symptoms is recommended
Which of the following statements is true regarding pain management
a. Pain is a vital protective mechanism that allows us to win and environment full of potential
dangers
b. Assessment of risk of developing substance use disorders for an individual patient only needs
to be done once at baseline
c. Short acting opioid medication's would usually be expected to eliminate a patient's pain
entirely
d. generally, non-opioid medications should be used first line prior to opioid medications -
ANSWER generally, non-opioid medications should be used first line prior to opioid medications
When starting opioid therapy for sub acute or chronic pain, reevaluate risks and benefits
a. Within one year after starting opioids I will be
b. Within 6-8 months after starting opioids I will be
c. Within 12-16 weeks after starting opioids I will be
d. Within 1-4 weeks after starting opioids I will be - ANSWER Within 1-4 weeks after starting
opioids I will be
